StockPriceToday

Intuitive Surgical Inc (ISRG)

ISRG stock price

Intuitive Surgical Inc. develops, manufactures, and markets robotic products designed to improve clinical outcomes for patients through minimally invasive surgery worldwide.

About Intuitive Surgical Inc

Intuitive Surgical Inc. develops, manufactures, and markets robotic surgical systems designed to enable minimally invasive surgery worldwide. The company's pioneering role in robotic surgery has made ISRG stock price sensitive to surgical procedure volumes and adoption rates of robotic surgical technology.

Intuitive Surgical's da Vinci surgical system allows surgeons to perform complex procedures through small incisions using robotic technology, resulting in potentially faster patient recovery times and improved surgical outcomes. The company's systems are used across various surgical specialties including urology, gynecology, and general surgery.

The company generates revenue through system sales, instrument and accessory sales, and service contracts, creating multiple revenue streams from its installed base. Intuitive Surgical's recurring revenue from instruments and services provides stability while new system placements drive growth, positively affecting ISRG stock price trends.

Intuitive Surgical's continued innovation in robotic surgical technology and expansion into new surgical applications position it well for long-term growth in the medical device market. The company's strong market position and the increasing adoption of minimally invasive surgical techniques remain important factors in its market valuation and future success.

ISRG Stock 12 Month Chart


Latest News for ISRG

Intuitive Surgical, Inc. (ISRG) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Intuitive announced that the FDA cleared its da Vinci single port (SP) surgical robot for use in new types of procedures.

Intuitive Surgical (ISRG) stock's surge may be overextended despite strong growth. See updated price targets and key risks before you invest.